SCIENCE

Weekly HIV Pill Shows Hope Amid Funding Cuts

Rio de Janeiro, Brazil (International AIDS Conference); World perspectiveWed Sep 02 2026
Weekly HIV Pill Shows Hope Amid Funding Cuts

Scientists announced a big win for HIV patients. A new pill could treat the virus once a week instead of daily. This changes how people manage their condition. Earlier treatments required many pills taken strictly. Those old regimens were hard to stick with. Now researchers hope this simpler approach works well. The news comes from a major international conference in Rio de Janeiro. Experts gathered to share updates on the fight against HIV.

But money problems are making things harder. The U.S. government cut its aid for HIV programs significantly. Funds dropped from eight point three billion dollars to six point two billion. That's a twenty-five percent decrease. Many health workers can't afford travel or registration fees now. Whole clinics are closing across the globe. Countries shut down nearly seventeen hundred HIV service sites. Prevention efforts suffered the biggest blow. Leaders say scientists did their job. Politicians need to act faster.

Meanwhile, a partnership between Gilead and Merck is testing a combo pill. This new drug combines two existing medicines. Early trial results look promising. They show the combination stops viral growth for one week. Both companies plan to send data to regulators soon. On a different front, the HPV vaccine is winning lives. Studies show it nearly eliminated cervical cancer deaths in young women. England reported zero deaths from the disease in the past five years. This represents a huge victory for public health.

actions